Aspirin Responsiveness in Women With Coronary Artery Disease
NCT01406990 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2012-09-28
Summary
The purpose of this study is to measure the percentage of women with known Coronary Artery Disease (CAD) who are hyporesponsive to low dose (81 mg) aspirin.
Conditions
Sponsors & Collaborators
-
Creighton University
lead OTHER
Principal Investigators
-
Katie Packard, PharmD · Creighton University
Eligibility
- Min Age
- 45 Years
- Max Age
- 85 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2012-04-30
- Completion
- 2012-04-30
Countries
- United States
Study Locations
More Related Trials
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
Women With Chest Pain and Normal Coronary Arteries Study
NCT00743197 ·Status: TERMINATED ·Phase: NA
-
Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome
NCT02520921 ·Status: COMPLETED ·Phase: PHASE4
-
Laboratory Aspirin Resistance in Diabetics and Non-Diabetics
NCT00563875 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease
NCT00501059 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Dose and Atherosclerosis in Patients With Heart Disease
NCT00272337 ·Status: COMPLETED ·Phase: PHASE4
-
The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)
NCT00250380 ·Status: COMPLETED
-
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
NCT05347069 ·Status: RECRUITING ·Phase: PHASE4
-
Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease
NCT03174990 ·Status: COMPLETED
-
Aspirin Effectiveness Study
NCT01113060 ·Status: UNKNOWN
-
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
NCT01276691 ·Status: COMPLETED ·Phase: PHASE4
-
Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients
NCT00129038 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay
NCT01023360 ·Status: UNKNOWN ·Phase: PHASE4
-
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
NCT00272311 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Attenuates Inflammation in Human Cerebral Aneurysms
NCT01710072 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
NCT00966485 ·Status: COMPLETED ·Phase: NA
-
Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
NCT00222261 ·Status: COMPLETED ·Phase: PHASE4
-
Timed Aspirin Chronobiome Study
NCT03590821 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Association of PeriOPerative Aspirin-ResisTance and CardioVascular Outcome
NCT04053894 ·Status: UNKNOWN
-
Prevalence and Level of Thienopyridine Resistance Seen in a Contemporary Percutaneous Coronary Intervention or Coronary Artery Bypass Graft Population
NCT01408927 ·Status: UNKNOWN
-
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
NCT01586975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients
NCT00681759 ·Status: COMPLETED
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
NCT04097912 ·Status: COMPLETED
-
Aspirin AM or PM: Effect on Circadian Rhythm of Platelet Reactivity
NCT01900639 ·Status: COMPLETED ·Phase: PHASE4